Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity

Regina S. Salvat, Deeptak Verma, Andrew S. Parker et al. · Proceedings of the National Academy of Sciences · 2017

Significance Nature produces a variety of proteins that could be tapped for therapeutic applications. This paper focuses on the bacterial enzyme β-lactamase, a component of antibody-directed enzyme prodrug therapies designed to activate cytotoxic prodrugs selectively at sites of malignancy. Unfortunately, like many other nonhuman proteins, β-lactamase evokes an antidrug immune response that limits its clinical potential. This paper demonstrates that a multiobjective library-design method enables incorporation of mutations throughout the protein, modifying portions that trigger immune recognition while simultaneously preserving stability and catalytic activity. The libraries were inherently enriched in beneficial variants, and they produced numerous candidates that were both highly functional and immunologically stealthy. The method is general purpose and could enable functional deimmunization of other biotherapeutic agents.

Cited by 37 works. doi:10.1073/pnas.1621233114

Authors

References